β3-integrins rather than β1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration

被引:94
作者
Slepian, MJ [1 ]
Massia, SP [1 ]
Dehdashti, B [1 ]
Fritz, A [1 ]
Whitesell, L [1 ]
机构
[1] Univ Arizona, Ctr Heart, Tucson, AZ 85724 USA
关键词
integrins; restenosis; cell adhesion molecules;
D O I
10.1161/01.CIR.97.18.1818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Smooth muscle cell (SMC) migration is a vital component in the response of the arterial wall to revascularization injury. Cell surface integrin-extracellular matrix interactions are essential for call migration. SMCs express both beta(1)- and beta(3)-integrins. In this study, we examined the relative functional roles of beta(1)- and beta(3)-integrin-matrix interactions in postinjury SMC mi,oration. Methods and Results-Flow cytometry and fluorescence microscopy of migrating SMCs immunostained with anti-Pi and anti-alpha(v) beta(3/5) antibodies (Abs) revealed expression of both beta(1)- and beta(3)-integrins, with beta(1) observed as linear streaks and beta(3) found in focal contacts. In a scrape-wound migration assay, anti-beta(1) Abs (92.0 +/- 10.7% of control, P=.1) and 0.5 mmol/L linear RGD (105+/-5% of control, P=.2) did not alter SMC migration at 48 hours after injury. beta(3)-Blockade, however, via Abs (anti-beta(3/5) 35.7+/-4.5% of control, anti-beta(3) 61+/-12% of control, both P<.001) and cyclic RGD (0.5 mmol/L) (12+/-10% of control, P<.001) decreased migration. Neither beta(1)- nor beta(3)-inhibition altered postinjury [H-3]thymidine incorporation. In the rat carotid injury model, local adventitial polymer-based delivery of radiolabeled linear or cyclic RGD led to uptake and retention of label, for both peptides, over a 72-hour period after injury. Local arterial wall beta(1)-blockade via polymer-based delivery of Linear RGD had no effect on SMC migration at 4.5 days (11.5+/-3.2 versus 12.8 SMCs per X600 field [control], P=.6) or on neointimal thickening at 14 days (I/M area ratio, 0.664+/-0.328 versus 1.179+/-0.324 [control], P=.6) after injury. In contrast, local beta(3)-blockade via cRGD limited migration (0.8+/-0.8 versus 12.8+/-4.4 SMCs per X600 field [control], P<.01) and thickening (J/M area ratio, 0.004+/-0.008 versus 1.179+/-0.324 [control], P<.01). Conclusions-In postinjury migrating SMCs, beta(3)- rather than beta(1)-integrin-matrix interactions are of greater functional significance in adhesive processes essential for SMC migration in vitro and in vivo. Blockade of dominant SMC integrin (beta(3))-matrix interactions may be a valuable approach for limiting injury-induced SMC migration and late arterial renarrowing.
引用
收藏
页码:1818 / 1827
页数:10
相关论文
共 52 条
[1]   INTEGRINS AND OTHER CELL-ADHESION MOLECULES [J].
ALBELDA, SM ;
BUCK, CA .
FASEB JOURNAL, 1990, 4 (11) :2868-2880
[2]   CYCLIC RGD PEPTIDE ANALOGS AS ANTIPLATELET ANTITHROMBOTICS [J].
BARKER, PL ;
BULLENS, S ;
BUNTING, S ;
BURDICK, DJ ;
CHAN, KS ;
DEISHER, T ;
EIGENBROT, C ;
GADEK, TR ;
GANTZOS, R ;
LIPARI, MT ;
MUIR, CD ;
NAPIER, MA ;
PITTI, RM ;
PADUA, A ;
QUAN, C ;
STANLEY, M ;
STRUBLE, M ;
TOM, JYK ;
BURNIER, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) :2040-2048
[3]   CHANGES IN THE FIBRONECTIN-SPECIFIC INTEGRIN EXPRESSION PATTERN MODIFY THE MIGRATORY BEHAVIOR OF SARCOMA S180 CELLS IN-VITRO AND IN THE EMBRYONIC ENVIRONMENT [J].
BEAUVAIS, A ;
ERICKSON, CA ;
GOINS, T ;
CRAIG, SE ;
HUMPHRIES, MJ ;
THIERY, JP ;
DUFOUR, S .
JOURNAL OF CELL BIOLOGY, 1995, 128 (04) :699-713
[4]   LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY [J].
BOLTON, AE ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1973, 133 (03) :529-538
[5]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[6]  
Brown MJ, 1996, CELL MOTIL CYTOSKEL, V34, P185, DOI 10.1002/(SICI)1097-0169(1996)34:3<185::AID-CM2>3.0.CO
[7]  
2-9
[8]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[9]  
CALIFF RM, 1991, J AM COLL CARDIOL, V17, pB2
[10]   MIGRATION OF SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS - CRITICAL EVENTS IN RESTENOSIS [J].
CASSCELLS, W .
CIRCULATION, 1992, 86 (03) :723-729